Data Management for Biotech Diligence: From Discovery to Development
Date: May 15, 2025
Time: 10 am PT | 1 pm ET
Presented in partnership with
The biotech market has rarely seen a contraction like we’ve witnessed in the past few weeks. Enterprise value for pre-clinical and early-stage sponsors are plummeting, and funding dollars are few and far between. The “doom and gloom” is being felt around the world, and it can feel like there’s nothing to be done.
But there ARE things you can do today to position yourself for the current market dynamics, protect your assets, and maximize their value - whether for fundraising, licensure, or sell off. And one essential but overlooked opportunity to protect and increase value is how you manage and store your data.
Data rooms are central in biotech: they not only underpin key events like fundraising, asset licensing, and M&A, but also actively inform R&D roadmap decisions. BD partnerships, pharma collaborations, asset sales, clinical prep, board updates, financing events – all depend on stakeholders having a reliable window into your data, with access to the latest information on your assets.
Getting your proverbial ducks in a row today means you are ready to pivot on a moment's notice. And in a fast-moving, uncertain market, that agility can become a path to survival, or even a strategic advantage.
Join us for this live webinar where we will cover:
-
What IS a virtual data room?
-
How does a data room relate to the diligence process?
-
What should be included in a data room, both in pre-clinical and clinical stages?
-
How to build, organize, and manage your data efficiently
Stay strong out there! 💪
Register Today

About the PresenterS
Toban Zolman has over 20 years of experience in the development and deployment of computerized systems for clinical trials. He has consulted at 47 of the top 50 pharma companies and worked directly with over 200 companies to align to electronic submissions standards. As CEO of Kivo, Toban leverages his many years of experience working with regulators combined with best practices in engineering and process management to bring life science software into the 21st century.
Bodgan Knezevic is CEO and Co-Founder of Kaleidoscope Bio. Bogdan's experience spans over 15 years of academic and industry science, including immunology, neuroscience, regenerative medicine, and genomics, and with an emphasis on preclinical drug discovery. At Kaleidoscope, Bogdan and his colleagues are combining depth of scientific expertise with best-in-class product, design, and engineering, to bring world-class tools to those who need them the most: Life Science teams working to advance human and planetary health.